Gossamer Bio Inc (NASDAQ:GOSS) price on current trading day, rose 11.76% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.88.
A look at the stock’s price movement, the close in the last trading session was $0.79, moving within a range at $0.76 and $0.9. The beta value (5-Year monthly) was 1.883. Turning to its 52-week performance, $1.55 and $0.50 were the 52-week high and 52-week low respectively. Overall, GOSS moved -27.81% over the past month.
Gossamer Bio Inc’s market cap currently stands at around $200.11 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-12.
Wall Street analysts have also projected the company’s year-on-year revenue to grow to 19.85M, representing a -82.69% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that GOSS is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
10 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 7 recommend GOSS as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
GOSS’s current price about -23.53% and -25.64% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 35.83, while 7-day volatility ratio is 17.27% and 11.17% in the 30-day chart. Further, Gossamer Bio Inc (GOSS) has a beta value of 1.86, and an average true range (ATR) of 0.12. Analysts have given the company’s stock an average 52-week price target of $4, forecast between a low of $2 and high of $5. Looking at the price targets, the low is -127.27% off current price level while to achieve the yearly target high, price needs to move -468.18%. Nonetheless, investors will most likely welcome a -354.55% jump to $4 which is the analysts’ median price.
If we refocus on Gossamer Bio Inc (NASDAQ:GOSS), historical trading data shows that trading volumes averaged 1.83 over the past 10 days and 1.50 million over the past 3 months. The company’s latest data on shares outstanding shows there are 226.60 million shares.
The 19.64% of Gossamer Bio Inc’s shares are in the hands of company insiders while institutional holders own 58.93% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.74 million on 2025-03-14, giving us a short ratio of 3.32. The data shows that as of 2025-03-14 short interest in Gossamer Bio Inc (GOSS) stood at 259.99998999999997 of shares outstanding, with shares short rising to 5.72 million registered in 2025-02-14. Current price change has pushed the stock -2.64% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GOSS stock continues to rise going into the next quarter.
